Bottled Sodium Chloride Injection Market Size in 2023, Impact of COVID-19, Growth, Share, Applications, SWOT analysis, Forecast 2028

Bottled Sodium Chloride Injection Market Sodium Chloride Injection, which is mostly the 0.9% sodium chloride water, also called as normal saline. It is a colorless, clear liquid. And it is sterile and no pyrogenic. They are parenteral solutions containing various concentrations of sodium chloride in water for injection intended for intravenous administration. Main ingredient of sodium chloride injection is sodium chloride. Sodium chloride is an electrolysis supplement agent. Sodium and chloride are important electrolysis for the human body and mainly exist in extracellular fluid, which play an important role in maintaining normal volume of blood, and extracellular fluid and osmosis pressure.
Market Analysis and Insights: Global Bottled Sodium Chloride Injection Market
Due to the COVID-19 pandemic, the global Bottled Sodium Chloride Injection market size is estimated to be worth USD million in 2023 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Plastic Bottle accounting for % of the Bottled Sodium Chloride Injection global market in 2021, is projected to value USD million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Bottled Sodium Chloride Injection market size is valued at USD million in 2021, while the US and Europe Bottled Sodium Chloride Injection are USD million and USD million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bottled Sodium Chloride Injection landscape, Germany is projected to reach USD million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Bottled Sodium Chloride Injection include Baxter, Kelun Group, Fresenius Kabi, BBraun, Shijiazhuang No.4 Pharmaceutical, Hospira (ICU Medical), CR Double-Crane, Otsuka and Cisen Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Bottled Sodium Chloride Injection Scope and Segment
Bottled Sodium Chloride Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bottled Sodium Chloride Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Get a sample PDF of the report athttps://www.marketgrowthreports.com/enquiry/request-sample/20055287

The Major Players in the Industrial Bottled Sodium Chloride Injection Market include:

  • Baxter
  • Kelun Group
  • Fresenius Kabi
  • BBraun
  • Shijiazhuang No.4 Pharmaceutical
  • Hospira (ICU Medical)
  • CR Double-Crane
  • Otsuka
  • Cisen Pharmaceutical
  • Huaren Pharmaceuticals
  • Dubang Pharmaceutical
  • Zhejiang Chimin
  • Guizhou Tiandi
  • Qidu Pharmaceutical

By Product Types:

  • Plastic Bottle
  • Glass Bottle

By Applications:

  • Hospitals
  • Clinics
  • Others

Enquire before Purchasing this Report: https://www.marketgrowthreports.com/enquiry/pre-order-enquiry/20055287











Related Articles

Back to top button